MAPT and tauopathy: At advanced stages, we demonstrate that the combined AD-like Aβ and tau transgenic expression resulted in increased amyloidosis and tauopathy as compared to that of the transgenic version of single pathologies, and, likewise, more marked cognitive impairments.